ZBTB3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.48260326027616E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.71514999999234E-05 |
Normal-vs-Stage2 |
4.383300E-03 |
Normal-vs-Stage3 |
1.48709933256441E-11 |
Normal-vs-Stage4 |
7.06000036210241E-10 |
Stage1-vs-Stage2 |
7.501600E-01 |
Stage1-vs-Stage3 |
1.11160000004773E-06 |
Stage1-vs-Stage4 |
8.590200E-04 |
Stage2-vs-Stage3 |
8.537600E-02 |
Stage2-vs-Stage4 |
1.907430E-01 |
Stage3-vs-Stage4 |
4.204400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.06209493924803E-11 |
Normal-vs-AfricanAmerican |
9.393400E-04 |
Normal-vs-Asian |
7.569600E-01 |
Caucasian-vs-AfricanAmerican |
8.707500E-02 |
Caucasian-vs-Asian |
3.774100E-02 |
AfricanAmerican-vs-Asian |
1.713980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.83829995670237E-09 |
Normal-vs-Female |
9.60389999749012E-08 |
Male-vs-Female |
8.302400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.57039999999898E-05 |
Normal-vs-Age(41-60Yrs) |
1.78912999999614E-05 |
Normal-vs-Age(61-80Yrs) |
6.36339980708556E-10 |
Normal-vs-Age(81-100Yrs) |
1.176060E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.652000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.109600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.650400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.136510E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.400500E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.911400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.541400E-01 |
Normal-vs-Grade 2 |
3.45420000003038E-06 |
Normal-vs-Grade 3 |
4.27939994551707E-09 |
Normal-vs-Grade 4 |
3.54039020322716E-12 |
Grade 1-vs-Grade 2 |
2.878000E-02 |
Grade 1-vs-Grade 3 |
1.036100E-04 |
Grade 1-vs-Grade 4 |
1.243220E-03 |
Grade 2-vs-Grade 3 |
2.665700E-02 |
Grade 2-vs-Grade 4 |
1.8711700000007E-05 |
Grade 3-vs-Grade 4 |
8.119400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.44339999958088E-07 |
Normal-vs-ccB subtype |
3.03939984291901E-10 |
ccA subtype-vs-ccB subtype |
1.258170E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.23569956886638E-10 |
Normal-vs-N1 |
1.587170E-04 |
N0-vs-N1 |
1.994580E-01 |
|
|